S&P Global Appoints Eric Aboaf as Chief Financial Officer

S&P Global (NYSE: SPGI)today announced the appointment of Eric Aboaf as Chief Financial Officer, effective February 2025. As an Executive Vice President and member of the Executive Leadership Team, Mr. Aboaf will oversee all aspects of the company’s Finance function. He will report to Ms. Martina L. Cheung, S&P Global’s incoming President and CEO. Ms. […]

SPHERE ENTERTAINMENT AND THE DEPARTMENT OF CULTURE AND TOURISM – ABU DHABI ANNOUNCE PLANS TO MAKE ABU DHABI NEXT SPHERE VENUE LOCATION

Sphere Entertainment Co. (NYSE: SPHR) (“Sphere Entertainment”) and the Department of Culture and Tourism – Abu Dhabi (“DCT Abu Dhabi”) announced today that they will work together to bring the world’s second Sphere to Abu Dhabi, United Arab Emirates. This next-generation entertainment medium is expected to be a landmark addition to this premier international capital

RNR Tire Express Announces 4 Key Leadership Promotions to Drive Continued Brand Expansion

— Adam Sutton Named CEO, Signaling Legacy Company’s Next Era of Growth — Additional Strategic Promotions Include New COO, President of Corporate Store Operations, and VP of Corporate Store Operations — Promotions Announced at Company Conference Amid Brand Strategy Planning, Touring of the Hankook Tire Plant, and More RNR Tire Express (RNR), the nation’s leading

BioPhotas Inc. Introduces the New ELITE Series 2

Celluma’s newest device is a medical-grade marvel in LED light therapy. BioPhotas Inc., makers of Celluma Light Therapy devices, have introduced the Celluma ELITE S2. Designed with medical professionals and high-end luxury spa practitioners in mind, the ELITE S2 is the most comprehensive and versatile professional-grade light therapy device to hit the market. For example,

Progressive Reports September 2024 Results

MAYFIELD VILLAGE, OHIO, Oct. 15, 2024 (GLOBE NEWSWIRE) — The Progressive Corporation (NYSE:PGR) today reported the following results for the month ended September 30, 2024 and the third quarter of 2024: September Quarter (millions, except per share amounts and ratios; unaudited) 2024 2024 2023 Change Net premiums written $ 6,570.0 $ 19,455.6 $ 15,593.8 25

Walnut Coding Donates Over $28,000 to Support Science Education for Rural Children

Walnut Coding, a leading online coding learning platformfor young learners, in partnership with Global People magazine, recently donated 200,000 yuan (approximately US$28,000) equivalent of educational materials to Guwangji Primary School in Henan Province, China. The charitable tour aims at enhancing the educational resources in underdeveloped areas, which included school supplies, books, and digital learning tools.

INTEGRACARE INC. EXPANDS TO BURLINGTON & OAKVILLE

Integracare Inc. a leader in private home healthcare in Toronto and Mississauga is expanding in Ontario to Burlington and Oakville through the acquisition of the Living Assistance Service Franchise in the area. https://mma.prnewswire.com/media/2528956/Integracare_Inc_INTEGRACARE_INC__EXPANDS_TO_BURLINGTON___OAKVILL.jpg Integracare has provided high quality senior home care services in Toronto and surrounding areas for over 30 years. Like Integracare, Living Assistance

Bestselling Author Glenn Llopis Releases Groundbreaking Manifesto for Healthcare Executives, Restoring Humanity in Healthcare Leadership

GLLG CEO, Glenn Llopis releases groundbreaking manifesto for Healthcare Executives, Restoring Humanity in Healthcare Leadership: Reinvent with Personalization available on Amazon.com October 15.From the boardroom and C-suite to the patient’s bedside-clinical and non-clinical-all agree: the center of everything we do is the person: Patients. Families. Employees. Individuals. The heart of healthcare is humanity. Yet, healthcare

Arbutus Announces Multiple Abstracts Highlighting Imdusiran Data Accepted for Presentation at AASLD – The Liver Meeting(R) 2024

WARMINSTER, Pa., Oct. 15, 2024 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq: ABUS), (“Arbutus” or the “Company”) a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop a functional cure for people with chronic hepatitis B virus (cHBV) infection, today announced that clinical data with imdusiran, an RNAi therapeutic, will be highlighted in four

Scroll to Top